These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 2208117

  • 41. Antisense oligonucleotides.
    Calabretta B, Skorski T, Zon G.
    Semin Cancer Biol; 1992 Dec; 3(6):391-8. PubMed ID: 1286160
    [Abstract] [Full Text] [Related]

  • 42. The influence of target protein half-life on the effectiveness of antisense oligonucleotide analog-mediated biologic responses.
    Spiller DG, Giles RV, Broughton CM, Grzybowski J, Ruddell CJ, Tidd DM, Clark RE.
    Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):281-93. PubMed ID: 9743466
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.
    Citro G, Szczylik C, Ginobbi P, Zupi G, Calabretta B.
    Br J Cancer; 1994 Mar; 69(3):463-7. PubMed ID: 8123474
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Effects of SCL antisense ooligonucleotides on K562 and CEM cell lines].
    Zheng ZJ, Hu JD, Huang SH, Wang SY, Lu LH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct; 10(5):404-8. PubMed ID: 12513737
    [Abstract] [Full Text] [Related]

  • 53. Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.
    Giles RV, Spiller DG, Grzybowski J, Clark RE, Nicklin P, Tidd DM.
    Nucleic Acids Res; 1998 Apr 01; 26(7):1567-75. PubMed ID: 9512525
    [Abstract] [Full Text] [Related]

  • 54. Interruption of activin A autocrine regulation by antisense oligodeoxynucleotides accelerates liver tumor cell proliferation.
    Takabe K, Lebrun JJ, Nagashima Y, Ichikawa Y, Mitsuhashi M, Momiyama N, Ishikawa T, Shimada H, Vale WW.
    Endocrinology; 1999 Jul 01; 140(7):3125-32. PubMed ID: 10385405
    [Abstract] [Full Text] [Related]

  • 55. The uptake kinetics of chimeric oligodeoxynucleotide analogues in human leukaemia MOLT-4 cells.
    Spiller DG, Tidd DM.
    Anticancer Drug Des; 1992 Apr 01; 7(2):115-29. PubMed ID: 1575885
    [Abstract] [Full Text] [Related]

  • 56. Antisense oligodeoxynucleotides.
    Stein CA, Narayanan R.
    Curr Opin Oncol; 1994 Nov 01; 6(6):587-94. PubMed ID: 7827170
    [Abstract] [Full Text] [Related]

  • 57. Investigations of antisense oligonucleotides targeted against bcl-2 RNAs.
    Kitada S, Miyashita T, Tanaka S, Reed JC.
    Antisense Res Dev; 1993 Nov 01; 3(2):157-69. PubMed ID: 8400801
    [Abstract] [Full Text] [Related]

  • 58. [Prospects for antisense therapy of human leukemias].
    Maekawa T.
    Hum Cell; 1996 Mar 01; 9(1):17-24. PubMed ID: 9183625
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Phosphorothioate oligodeoxynucleotides--anti-sense inhibitors of gene expression?
    Stein CA, Tonkinson JL, Yakubov L.
    Pharmacol Ther; 1991 Dec 01; 52(3):365-84. PubMed ID: 1668180
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.